Exploiting homing abilities of cell carriers: Targeted delivery of nanoparticles for cancer therapy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Biochemical Pharmacology

• Publication date

  2017-12-01

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.bcp.2017.09.006PMID 28941937PMCID PMC5681359
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intraperitoneal Administration of Neural Stem Cell-Nanoparticle Conjugates Targets Chemotherapy to Ovarian Tumors.

  2017cited by this paper
• Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence.

  2017cited by this paper
• Delivering safer immunotherapies for cancer

  2017cited by this paper
• Materializing the future of vaccines and immunotherapy

  2016cited by this paper
• Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.

  2016cited by this paper
• Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?

  2016cited by this paper
• Antibody-drug conjugates—an emerging class of cancer treatment

  2016cited by this paper
• Nanoparticles in the clinic

  2016cited by this paper
• Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

  2016cited by this paper
• Analysis of nanoparticle delivery to tumours

  2016cited by this paper
• CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing

  2016cited by this paper
• Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy

  2016cited by this paper
• Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy.

  2016cited by this paper
• Controlled Payload Release by Magnetic Field Triggered Neural Stem Cell Destruction for Malignant Glioma Treatment

  2016cited by this paper
• A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: Preclinical activity and safety in nonhuman primates

  2015cited by this paper
• Controlled Drug Release from Pharmaceutical Nanocarriers.

  2015cited by this paper
• Biodegradable and Renal Clearable Inorganic Nanoparticles

  2015cited by this paper
• Principles of nanoparticle design for overcoming biological barriers to drug delivery

  2015cited by this paper
• Design strategies and applications of circulating cell-mediated drug delivery systems.

  2015cited by this paper
• Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells

  2015cited by this paper
• Prescription for a pharmacyte

  2015cited by this paper
• Neutrophil-Mediated Delivery of Therapeutic Nanoparticles across Blood Vessel Barrier for Treatment of Inflammation and Infection.

  2015cited by this paper
• Synthesis and surface functionalization of silica nanoparticles for nanomedicine.

  2014cited by this paper
• Nano-engineered mesenchymal stem cells as targeted therapeutic carriers.

  2014cited by this paper
• Neural stem cells improve intracranial nanoparticle retention and tumor-selective distribution.

  2014cited by this paper
• Neural Stem Cell-Mediated Intratumoral Delivery of Gold Nanorods Improves Photothermal Therapy

  2014cited by this paper
• Antibody-drug conjugates: an emerging concept in cancer therapy.

  2014cited by this paper
• Conjugation of pH-responsive nanoparticles to neural stem cells improves intratumoral therapy.

  2014cited by this paper
• Nanoparticle-programmed self-destructive neural stem cells for glioblastoma targeting and therapy.

  2013cited by this paper
• Liposome: classification, preparation, and applications

  2013cited by this paper
• Neural Stem Cell–Mediated Enzyme/Prodrug Therapy for Glioma: Preclinical Studies

  2013cited by this paper
• Nonporous Silica Nanoparticles for Nanomedicine Application.

  2013cited by this paper
• [Mesenchymal stem cells as an antitumor therapy tool].

  2013cited by this paper
• Mesenchymal stem cells as an antitumor therapy tool

  2013cited by this paper
• Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology.

  2013influential reference
• A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics.

  2013cited by this paper
• The integration of T cell migration, differentiation and function

  2013cited by this paper
• Gold Nanoparticle‐Loaded Neural Stem Cells for Photothermal Ablation of Cancer

  2013cited by this paper
• Expert opinion: Responsive polymer nanoparticles in cancer therapy.

  2012cited by this paper
• PLGA-based nanoparticles: an overview of biomedical applications.

  2012cited by this paper
• Particle-mediated delivery of cytokines for immunotherapy.

  2012cited by this paper
• HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes

  2012cited by this paper
• Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery

  2012cited by this paper
• Macromolecular therapeutics in cancer treatment: the EPR effect and beyond.

  2012cited by this paper
• Use of macrophages to deliver therapeutic and imaging contrast agents to tumors.

  2012cited by this paper
• Odyssey of a cancer nanoparticle: from injection site to site of action.

  2012cited by this paper
• The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy.

  2011cited by this paper
• Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.

  2011cited by this paper
• Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy.

  2011cited by this paper
• Enhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials.

  2011cited by this paper
• Therapeutic cell engineering using surface-conjugated synthetic nanoparticles

  2010cited by this paper
• Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release

  2010cited by this paper
• Advances in polymeric micelles for drug delivery and tumor targeting.

  2010cited by this paper
• Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art.

  2010cited by this paper
• Mesenchymal Stem Cell Carriers Protect Oncolytic Measles Viruses from Antibody Neutralization in an Orthotopic Ovarian Cancer Therapy Model

  2009cited by this paper
• Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.

  2009cited by this paper
• Nanoparticles for drug delivery in cancer treatment.

  2008cited by this paper
• Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma

  2008cited by this paper
• Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer

  2008cited by this paper
• A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors.

  2007cited by this paper
• Nanoparticles in modern medicine: State of the art and future challenges

  2007cited by this paper
• Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma

  2007cited by this paper
• Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses

  2006cited by this paper
• Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer

  2004cited by this paper
• Nanoparticle and targeted systems for cancer therapy.

  2004cited by this paper
• Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas.

  2000cited by this paper
• Novel applications of liposomes.

  1998cited by this paper
• A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

  1986cited by this paper

• Precision Nanotechnology: Revolutionizing Therapeutic Strategies Against Drug-Resistant Breast Cancer.

  2026cites this paper
• Development of liposome-loaded macrophages as tumor-targeted drug delivery carriers: Impact of macrophage phenotypes on their liposome-loading capacity and tumor-homing potential

  2025cites this paper
• Smart Cells Against Cancer: Advances in Cell-Based Drug Delivery and Diagnostics

  2025cites this paper
• Nano-biohybrid systems for the targeted delivery of chemotherapeutics.

  2025cites this paper
• Interactions Between Active Matters and Endogenous Fields

  2025cites this paper
• Liposome-Loaded Mesenchymal Stem Cells Enhance Tumor Accumulation and Anti-Tumor Efficacy of Doxorubicin in Mouse Tumor Models of Melanoma

  2025cites this paper
• Ajwain-assisted synthesis of oxalipalladium nanoparticles for colorectal cancer treatment: enhanced anticancer activity and protein interaction profiling

  2024cites this paper
• Advances in nanotechnology-based approaches for the treatment of head and neck squamous cell carcinoma

  2024cites this paper
• A versatile method for conjugating lipid nanoparticles on T cells through combination of click chemistry and metabolic glycoengineering

  2024cites this paper
• Chemotactic Micro/Nanomotors for Biomedical Applications.

  2023cites this paper
• Cell-Based Drug Delivery Systems with Innate Homing Capability as a Novel Nanocarrier Platform

  2023cites this paper
• Engineering Macrophages via Nanotechnology and Genetic Manipulation for Cancer Therapy

  2022cites this paper
• Mesenchymal stem cells: a living carrier for active tumor-targeted delivery.

  2022cites this paper
• Nanotechnology-Assisted Cell Tracking

  2022cites this paper
• A nano-enhanced vaccine for metastatic melanoma immunotherapy

  2022cites this paper
• A Critical Scrutiny on Liposomal Nanoparticles Drug Carriers as Modelled by Topotecan Encapsulation and Release in Treating Cancer

  2022cites this paper
• Nanotechnology reinforced neutrophil-based therapeutic strategies for inflammatory diseases therapy

  2022cites this paper
• Engineered macrophages as near-infrared light activated drug vectors for chemo-photodynamic therapy of primary and bone metastatic breast cancer

  2021cites this paper
• Investigating the in vivo biodistribution of extracellular vesicles isolated from various human cell sources using positron emission tomography

  2021cites this paper
• Endothelial cell membrane-based biosurface for targeted delivery to acute injury: analysis of leukocyte-mediated nanoparticle transportation.

  2021cites this paper
• Neutrophil-mediated transport is crucial for short-circulating magnetic nanoparticles delivery to tumors.

  2020cites this paper
• F7 and topotecan co-loaded thermosensitive liposome as a nano-drug delivery system for tumor hyperthermia

  2020cites this paper
• Hybrid nanosilicas produced by the Stöber sol-gel process: In vitro evaluation in MRC-5 cells

  2020cites this paper
• MnO2@Ce6-loaded mesenchymal stem cells as an "oxygen-laden guided-missile" for the enhanced photodynamic therapy on lung cancer.

  2020cites this paper
• Folate-grafted glycyl-glycine-melphalan conjugate self-assembled amphilphilc nanomicelles augmented drug delivery, cytotoxicity and cellular uptake in human ovarian cancer cells

  2020cites this paper
• Surgery-Guided Removal of Ovarian Cancer Using Up-Converting Nanoparticles.

  2020cites this paper
• Cytokine-induced killer cells-assisted tumor-targeting delivery of Her-2 monoclonal antibody-conjugated gold nanostars with NIR photosensitizer for enhanced therapy of cancer.

  2020cites this paper
• Aptamers against mouse and human tumor-infiltrating myeloid cells as reagents for targeted chemotherapy

  2020cites this paper
• Nanoparticles as Delivery Systems in Cancer Therapy

  2019cites this paper
• Tracking stem cells and macrophages with gold and iron oxide nanoparticles – The choice of the best suited particles

  2019cites this paper
• Nanoparticle-mediated local delivery of pioglitazone attenuates bleomycin-induced skin fibrosis.

  2019cites this paper
• Recent advances in cell-mediated nanomaterial delivery systems for photothermal therapy.

  2018cites this paper
• Tumor Heterogeneity: An Important Determinant for Efficacy and Safety in Nanoparticle Anticancer Gene Therapy.

  2018cites this paper